Home Business Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

316
5
Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

Gilead Sciences will acquire biotech company Immunomedics in a $21 billion deal that will expand Gilead’s availability of cancer treatments, the companies announced on Sunday. 
The deal will provide…
Read More

5 COMMENTS

  1. 850362 11447A genuinely exciting examine, I could possibly not concur entirely, but you do make some genuinely legitimate points. 138660

  2. 46416 98844You completed several good points there. I did specific searches on the concern and discovered numerous individuals go in conjunction with along along with your weblog. 471214

  3. 443085 516611Maximize your by how a large amount of gear are employed internationally and will often impart numerous memory employing that your is also fighting that can be a result from our team rrnside the twenty 1st centuries. everyday deal livingsocial discount baltimore washington 351196

  4. 256698 453710I like the beneficial data you supply within your articles. Ill bookmark your weblog and check once again here regularly. Im quite certain I will learn lots of new stuff correct here! Finest of luck for the next! 799408

LEAVE A REPLY

Please enter your comment!
Please enter your name here